Insys Therapeutics Finally Launched Its Highly Anticipated Drug

By:
Insys Therapeutics Finally Launched Its Highly Anticipated Drug

Flickr / Thomas Hawk / (CC BY-NC 2.0)

If you look around, chances are you won’t find many marijuana stocks struggling.

Cannabis research firm ArcView is estimating that legal sales growth in North America could average 26% through 2021, leading to a nearly $22 billion market within five years.

But there’s always an outlier — and for the marijuana industry that’s drugmaker Insys Therapeutics (NASDAQ: INSY). While a dozen of the largest pot stocks have rallied over the trailing year, it’s the lone marijuana stock that’s moved lower.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top